SIgAD patients showed significantly an increased frequency of CD19+ B-cells [11.2% (9.4–13.07%) vs. 7.2% (6–8.6%), p < 0.001], with increased naïve B-cells [71% (63.7–80%) vs. Here, CD19 is linked to selective IgA deficiency disease.